Skip to main content
Top
Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2023

Open Access 01-12-2023 | Guillain-Barré Syndrome | Research

Seroprevalence of Campylobacter jejuni infection in common subtypes of Guillain–Barre syndrome in Kashmiri population

Authors: Feroze Mir, Waseem Dar, Arjimand Yaqoob, Maqbool Wani, Ravouf Asmi, Mushtaq Wani

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2023

Login to get access

Abstract

Background

Guillain–Barre Syndrome (GBS) is a common differential diagnosis of acute-onset flaccid quadriparesis with or without bulbar involvement. Various illnesses precede GBS, respiratory illness being the most common. Campylobacter jejuni is the single most common organism found associated with GBS. The aim of the present study was to determine the prevalence of Campylobacter jejuni positivity in different subtypes of GBS.

Methods

Sixty patients of GBS were tested for serological evidence of Campylobacter jejuni and compared with 60 age and sex matched controls.

Results

Mean age of cases was 39.58 (± 14.76 years) and that of controls was 35 (± 12.31 years). Preceding illness was present in 38% cases. Respiratory tract illness was present in 9 (15%) cases, while as GI illness was present in 8 (13%) cases. AIDP was the most common variant accounting for 65% of cases, followed by AMAN (18.3%). Among cases, 24 (40%) tested positive for Campylobacter jejuni antibody whereas only 12 (20%) tested positive for antibody among controls. The difference was statistically significant between cases and controls (p value = 0.003). There was no statistically significant difference in antibody positivity and preceding illness among different variants of GBS (p value = 1.0).

Conclusion

Campylobacter jejuni infection is a frequent preceding illness in GBS patients, although it may be asymptomatic. There is however no relation between different subtypes of GBS and C. jejuni infection.
Literature
2.
go back to reference van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.CrossRefPubMed van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.CrossRefPubMed
5.
go back to reference Willison HJ, Jacobs BC, van Doorn PA. Guillain–Barré syndrome. The Lancet. 2016;388(10045):717–27.CrossRef Willison HJ, Jacobs BC, van Doorn PA. Guillain–Barré syndrome. The Lancet. 2016;388(10045):717–27.CrossRef
7.
go back to reference Mamishi S, Ashrafi MR, Mohammadi M, Zamani G, Pourakbari B, Mahmoudi S, et al. Cytomegalovirus infection and Guillain–Barré syndrome: the first case-control study in Iran. Iran J Child Neurol. 2021;15(4):35–41.PubMedPubMedCentral Mamishi S, Ashrafi MR, Mohammadi M, Zamani G, Pourakbari B, Mahmoudi S, et al. Cytomegalovirus infection and Guillain–Barré syndrome: the first case-control study in Iran. Iran J Child Neurol. 2021;15(4):35–41.PubMedPubMedCentral
8.
go back to reference Wallace LA, English SW, Fugate JE, Tosh PK. Acute Epstein-Barr virus infection presenting as Guillain-Barre syndrome. IDCases. 2021;1(25): e01196.CrossRef Wallace LA, English SW, Fugate JE, Tosh PK. Acute Epstein-Barr virus infection presenting as Guillain-Barre syndrome. IDCases. 2021;1(25): e01196.CrossRef
9.
go back to reference Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, et al. Mycoplasma pneumoniae triggering the Guillain–Barré syndrome: a case-control study. Ann Neurol. 2016;80(4):566–80.CrossRefPubMed Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, et al. Mycoplasma pneumoniae triggering the Guillain–Barré syndrome: a case-control study. Ann Neurol. 2016;80(4):566–80.CrossRefPubMed
10.
go back to reference Mori M, Kuwabara S, Miyake M, Noda M, Kuroki H, Kanno H, et al. Haemophilus influenzae infection and Guillain–Barré syndrome. Brain J Neurol. 2000;123(Pt 10):2171–8.CrossRef Mori M, Kuwabara S, Miyake M, Noda M, Kuroki H, Kanno H, et al. Haemophilus influenzae infection and Guillain–Barré syndrome. Brain J Neurol. 2000;123(Pt 10):2171–8.CrossRef
11.
go back to reference Jacobs BC, Rothbarth PH, van der Meché FGA, Herbrink P, Schmitz PIM, de Klerk MA, et al. The spectrum of antecedent infections in Guillain–Barré syndrome: a case-control study. Neurology. 1998;51(4):1110–5.CrossRefPubMed Jacobs BC, Rothbarth PH, van der Meché FGA, Herbrink P, Schmitz PIM, de Klerk MA, et al. The spectrum of antecedent infections in Guillain–Barré syndrome: a case-control study. Neurology. 1998;51(4):1110–5.CrossRefPubMed
12.
go back to reference Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain–Barré syndrome. Drug Saf. 2009;32(4):309–23.CrossRefPubMed Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain–Barré syndrome. Drug Saf. 2009;32(4):309–23.CrossRefPubMed
14.
go back to reference Huang C, Zhang Y, Deng S, Ren Y, Lu W. Trauma-related Guillain–Barré syndrome: systematic review of an emerging concept. Front Neurol. 2020;6(11): 588290.CrossRef Huang C, Zhang Y, Deng S, Ren Y, Lu W. Trauma-related Guillain–Barré syndrome: systematic review of an emerging concept. Front Neurol. 2020;6(11): 588290.CrossRef
16.
17.
go back to reference Svedhem A, Kaijser B. Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden. J Infect Dis. 1980;142(3):353–9.CrossRefPubMed Svedhem A, Kaijser B. Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden. J Infect Dis. 1980;142(3):353–9.CrossRefPubMed
18.
go back to reference Nyati KK, Nyati R. Role of Campylobacter jejuni infection in the pathogenesis of Guillain–Barré Syndrome: an update. BioMed Res Int. 2013;13(2013): e852195. Nyati KK, Nyati R. Role of Campylobacter jejuni infection in the pathogenesis of Guillain–Barré Syndrome: an update. BioMed Res Int. 2013;13(2013): e852195.
20.
go back to reference Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27(Suppl):S21-24.CrossRefPubMed Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27(Suppl):S21-24.CrossRefPubMed
21.
go back to reference Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet Lond Engl. 1978;2(8093):750–3.CrossRef Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet Lond Engl. 1978;2(8093):750–3.CrossRef
22.
go back to reference Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989;12(6):435.CrossRefPubMed Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989;12(6):435.CrossRefPubMed
23.
go back to reference Leonhard SE, van der Eijk AA, Andersen H, Antonini G, Arends S, Attarian S, et al. An international perspective on preceding infections in Guillain–Barré syndrome: the IGOS-1000 cohort. Neurology. 2022;99(12):e1299–313.CrossRefPubMed Leonhard SE, van der Eijk AA, Andersen H, Antonini G, Arends S, Attarian S, et al. An international perspective on preceding infections in Guillain–Barré syndrome: the IGOS-1000 cohort. Neurology. 2022;99(12):e1299–313.CrossRefPubMed
24.
go back to reference Schmidt-Ott R, Schmidt H, Feldmann S, Brass F, Krone B, Gross U. Improved serological diagnosis stresses the major role of Campylobacter jejuni in Triggering Guillain–Barré syndrome. Clin Vaccine Immunol. 2006;13(7):779–83.CrossRefPubMedPubMedCentral Schmidt-Ott R, Schmidt H, Feldmann S, Brass F, Krone B, Gross U. Improved serological diagnosis stresses the major role of Campylobacter jejuni in Triggering Guillain–Barré syndrome. Clin Vaccine Immunol. 2006;13(7):779–83.CrossRefPubMedPubMedCentral
25.
go back to reference Schiaffino F, Kosek MN. Intestinal and extra-intestinal manifestations of campylobacter in the immunocompromised host. Curr Treat Options Infect Dis. 2020;12(4):361–74.CrossRef Schiaffino F, Kosek MN. Intestinal and extra-intestinal manifestations of campylobacter in the immunocompromised host. Curr Treat Options Infect Dis. 2020;12(4):361–74.CrossRef
27.
go back to reference Allos BM. Association between Campylobacter infection and Guillain–Barré syndrome. J Infect Dis. 1997;176(Suppl 2):S125-128.CrossRefPubMed Allos BM. Association between Campylobacter infection and Guillain–Barré syndrome. J Infect Dis. 1997;176(Suppl 2):S125-128.CrossRefPubMed
28.
go back to reference Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, et al. A bacterium lipopolysaccharide that elicits Guillain–Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993;178(5):1771–5.CrossRefPubMed Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, et al. A bacterium lipopolysaccharide that elicits Guillain–Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993;178(5):1771–5.CrossRefPubMed
29.
go back to reference Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, et al. Campylobacter jejuni strains from patients with Guillain–Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993;33(3):243–7.CrossRefPubMed Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, et al. Campylobacter jejuni strains from patients with Guillain–Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993;33(3):243–7.CrossRefPubMed
30.
go back to reference Gruenewald R, Ropper AH, Lior H, Chan J, Lee R, Molinaro VS. Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain–Barré syndrome. Arch Neurol. 1991;48(10):1080–2.CrossRefPubMed Gruenewald R, Ropper AH, Lior H, Chan J, Lee R, Molinaro VS. Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain–Barré syndrome. Arch Neurol. 1991;48(10):1080–2.CrossRefPubMed
31.
go back to reference Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain–Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995;118(3):597–605.CrossRefPubMed Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain–Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995;118(3):597–605.CrossRefPubMed
32.
go back to reference Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain–Barré syndrome. Brain. 2018;141(10):2866–77.CrossRefPubMed Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain–Barré syndrome. Brain. 2018;141(10):2866–77.CrossRefPubMed
33.
go back to reference Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain–Barré syndrome. N Engl J Med. 1995;333(21):1374–9.CrossRefPubMed Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain–Barré syndrome. N Engl J Med. 1995;333(21):1374–9.CrossRefPubMed
34.
go back to reference Sharma A, Lal V, Modi M, Vaishnavi C, Prabhakar S. Campylobacter jejuni infection in Guillain–Barré syndrome: a prospective case control study in a tertiary care hospital. Neurol India. 2011;59(5):717.CrossRefPubMed Sharma A, Lal V, Modi M, Vaishnavi C, Prabhakar S. Campylobacter jejuni infection in Guillain–Barré syndrome: a prospective case control study in a tertiary care hospital. Neurol India. 2011;59(5):717.CrossRefPubMed
Metadata
Title
Seroprevalence of Campylobacter jejuni infection in common subtypes of Guillain–Barre syndrome in Kashmiri population
Authors
Feroze Mir
Waseem Dar
Arjimand Yaqoob
Maqbool Wani
Ravouf Asmi
Mushtaq Wani
Publication date
01-12-2023
Publisher
Springer Berlin Heidelberg
DOI
https://doi.org/10.1186/s41983-023-00764-x

Other articles of this Issue 1/2023

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2023 Go to the issue